Searched for
SANOFI INDIA EARNINGS
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat is evident in the last few trading sessions is how the street is treating Q4 earnings numbers. If a company delivers in terms of numbe...- Buy Sanofi India, target price Rs 6738: ICICI SecuritiesSanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 12894.50 Crore) operating in Pharmaceutic...
- Add Sanofi India, target price Rs 8107: ICICI SecuritiesSanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 16767.21 Crore) operating in Pharmaceutic...
- Sanofi India skids 2% on poor earnings scorecardSanofi India’s counter fell to a low of Rs 7,159 as against the previous close of Rs 7,280.40 on the National Stock Exchange.
- Sanofi India Q3 results: Co posts net profit at Rs 530 croreSanofi India board in its meeting held on July 27 had approved a transaction for slump sale and transfer of its nutraceuticals business to ...
- Add Sanofi India, target price Rs 7,680: CentrumRevenue growth excluding export for the domestic business continues to be at mid-high single digits.
- Trending stocks: Sanofi India shares up over 1%A total of 330 shares changed hands on the counter till 10:50AM (IST).
- Sanofi India Q1 results: Met profit declines 8% to Rs 85.4 croreThe company had posted a net profit of Rs 92.9 crore for the same period previous fiscal, Sanofi India said in a regulatory filing.
- Analysts slash Sanofi target over Ankleshwar plant saleThe stock ended flat at ₹5,928 on Friday.
- Sanofi India Q1 profit up 13% to Rs 93 croreTotal income stood at Rs 740.3 crore during the quarter, compared with Rs 640.3 crore in the year-ago period.
- Sanofi India posts 25 per cent rise in Q1 net profitDuring the quarter, the company said its total expenses increased to Rs 445.4 crore as compared with Rs 431.9 crore.
- Sanofi India Q2 net up 12% at Rs 64.2 croreThe company, which follows January-December financial year, had posted a net profit of Rs 57.5 crore in the corresponding period of the pre...
- CCI imposes penalty on pharma majors GlaxosmithKline and Sanofi IndiaCCI has imposed a Rs 60 crore penalty on pharma majors GlaxosmithKline and Rs 3 crore on Sanofi India for indulging in unfair trade practic...
- Sanofi Q1 net up 24.75 per cent at Rs 64.5 croreThe net of tax at Rs 16.1 crore arising from the sale of a floor at a commercial premises in Mumbai in January 2015 has been indicated as e...
- Sanofi India shares up 3 per cent; m-cap surges by Rs 268 croreShares of Sanofi India settled for the day with gains of over 3 per cent on the BSE, thereby adding Rs 268 crore to its market capitalisati...
- Sanofi India stock likely to be re-rated on company's improving fundamentalsHowever, unlike other multinational pharmaceutical companies, Sanofi India was not analysts’ favourite for quite some time.
- Sanofi India Q2 Net up 26% to Rs 51.2 croreDrug firm Sanofi India today reported a 26.41 per cent rise in net profit to Rs 51.2 crore for the quarter ended June 30, 2013, mainly on a...
- Sanofi India net down 6.38 pc at Rs 51.3 cr in July-SeptemberDrug firm Sanofi India today said its net profit declined by 6.38 per cent to Rs 51.3 crore for the quarter ended September 30, 2012, mainl...
- Piramal Health up 13% on Sanofi stake buyThe news of French drug major Sanofi-Aventis picking up stake in Piramal Healthcare at a premium has resulted in its stock price trading at...
- Sanofi seen ahead in Piramal raceSanofi-Aventis has completed due diligence and the deal could be closed soon, one of the two persons told ET on condition of anonymity.
Load More
